Clinton Thurber, MD
Clinical Cardiac Electrophysiology · Ogden, UTNPI 1467862573
Payments from drug & device makers
What this record shows
This record is dominated by grants: $14,821 of the $20,748 with a category attached, or 71.4%. Medtronic accounts for 62.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $7,800 and has fallen 84.6% since, to $1,199 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in UT, where the typical reported total is $33,716.
Across 84 payments — averaging $247.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$13K
- Boston Scientific$5K
- Biosense Webster, Inc.$1K
- Abbott$513
- Medical Device Business Services, Inc.$300
- Atricure, Inc.$231
- plus $245 from 5 others
Across 25 payments — averaging $793.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$20K
What the payments were for
- Grants$14,82171%
- Travel & lodging$9475%
- Food & beverage$4,31821%
- Education$6613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 26 | $12,994 |
| Boston Scientific | 27 | $5,421 |
| Biosense Webster, Inc. | 11 | $1,044 |
| Abbott | 5 | $513 |
| Medical Device Business Services, Inc. | 1 | $300 |
| Atricure, Inc. | 4 | $231 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $86 |
| Biotronik Inc. | 1 | $75 |
| Novartis | 3 | $53 |
| Johnson & Johnson | 1 | $18 |
| Chiesi USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$3,750
- Carto 3$825
- COBALT DR MRI SURESCAN$633
- AZURE XT DR MRI SURESCAN$248
- Micra$246
- RESONATE EL ICD VR$218
- HeartMate II LVAS$200
- OCTARAY MAPPING CATHETER$171
- ATRICLIP LAA EXCLUSION SYSTEM$164
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$164
- EnSite Precision Cardiac Mapping System$159
- EMBLEM MRI S-ICD$151
- NUVISION ICE CATHETER$149
- QUADRA ALLURE MP$116
- WATCHMAN FLX$109
How this compares
$20,748 in reported general payments places this provider in the 40th percentile of 29 clinical cardiac electrophysiology providers in Utah.
See all clinical cardiac electrophysiology providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 399 | $535,846 |
| XareltoRivaroxaban | 131 | $146,277 |
| EntrestoSacubitril/Valsartan | 27 | $40,624 |
| MultaqDronedarone Hcl | 12 | $9,361 |
| Propafenone Hcl ErPropafenone Hcl | 28 | $5,631 |
| Metoprolol Succinate | 218 | $4,524 |
| Mexiletine Hcl | 26 | $3,685 |
| Flecainide Acetate | 30 | $2,149 |
| SotalolSotalol Hcl | 77 | $1,644 |
| Pantoprazole Sodium | 95 | $1,309 |
| Amiodarone Hcl | 73 | $1,156 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 45 | $1,113 |
| Verapamil ErVerapamil Hcl | 19 | $531 |
| Carvedilol | 55 | $462 |
| Potassium Chloride | 22 | $380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $18 | $146,277131 claims |
| NovartisEntresto | $53 | $40,62427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 29 clinical cardiac electrophysiology providers in Utah.
Other clinical cardiac electrophysiology in Ogden
- Dan DanOgden$40K
- Yonathan MelmanOgden$8K
- Peter ForstallOgden$6K
- Ravi RanjanSalt Lake City$345K
- John DaySalt Lake City$313K
- Chun HwangProvo$289K
- Roger FreedmanSalt Lake City$177K
- Douglas PackerMurray$169K
- Sandeep TalwarFarmington$82K
- Michael CutlerMurray$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.